Browse Drug Recalls

68 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 68 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 68 FDA drug recalls.

Clear
DateProductReasonClassFirm
Oct 13, 2016 AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Indi... Presence of Foreign Tablets/Capsules Class III Amerisource Health Services
Sep 30, 2016 Paricalcitol Capsules, 1 mcg, packaged in 30 Capsules (5 x 6) per carton (NDC... Failed Impurities/Degradation Specifications: This repackaged product was recalled by its manufac... Class III Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 24, 2016 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule Class II Amerisource Health Services
Aug 4, 2016 buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count ... Failed dissolution specifications - the out of specification result for dissolution was identifie... Class III Amerisource Health Services
Mar 31, 2016 Fenofibrate Capsules (Micronized), 200 mg , 30-count Unit Dose Blister Packs ... Labeling: Incorrect or Missing Lot and/or Exp Date Class III Amerisource Health Services
Mar 31, 2016 Fenofibrate Capsules (Micronized), 134 mg Capsules, 20-count Unit Dose Bliste... Labeling: Incorrect or Missing Lot and/or Exp Date Class III Amerisource Health Services
Jan 26, 2016 Candesartan Cilexetil Tablets, 16 mg, 30 Tablets (5 x 6) blister pack, Rx, Di... Failed Impurities/Degradation Specifications; 9 month stability (manufacturer) Class III Amerisource Health Services
Jan 18, 2016 Levofloxacin Tablets USP, 500 mg, packaged in 100-count (10 x 10) blister car... Failed Dissolution Specifications: Unexplained low out of specification results for dissolution. Class II Amerisource Health Services
Oct 29, 2015 HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 10 cap/blister, 100-count carton,... Presence of Particulate Matter Class II Amerisource Health Services

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.